These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35299744)

  • 61. Building CT Radiomics Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction.
    Shen C; Liu Z; Wang Z; Guo J; Zhang H; Wang Y; Qin J; Li H; Fang M; Tang Z; Li Y; Qu J; Tian J
    Transl Oncol; 2018 Jun; 11(3):815-824. PubMed ID: 29727831
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictive performance of ultrasonography-based radiomics for axillary lymph node metastasis in the preoperative evaluation of breast cancer.
    Lee SE; Sim Y; Kim S; Kim EK
    Ultrasonography; 2021 Jan; 40(1):93-102. PubMed ID: 32623841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonenhanced MRI-based radiomics model for preoperative prediction of nonperfused volume ratio for high-intensity focused ultrasound ablation of uterine leiomyomas.
    Zheng Y; Chen L; Liu M; Wu J; Yu R; Lv F
    Int J Hyperthermia; 2021; 38(1):1349-1358. PubMed ID: 34486913
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
    Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.
    Dong Y; Feng Q; Yang W; Lu Z; Deng C; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Liang C; Zhang B; Zhang S
    Eur Radiol; 2018 Feb; 28(2):582-591. PubMed ID: 28828635
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients.
    Chen S; Shu Z; Li Y; Chen B; Tang L; Mo W; Shao G; Shao F
    Front Oncol; 2020; 10():1410. PubMed ID: 32923392
    [No Abstract]   [Full Text] [Related]  

  • 69. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
    Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
    Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
    [No Abstract]   [Full Text] [Related]  

  • 70. Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer.
    Chen X; Zhuang Z; Pen L; Xue J; Zhu H; Zhang L; Wang D
    Abdom Radiol (NY); 2024 May; 49(5):1363-1375. PubMed ID: 38305796
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An overview of meta-analyses on radiomics: more evidence is needed to support clinical translation.
    Zhong J; Lu J; Zhang G; Mao S; Chen H; Yin Q; Hu Y; Xing Y; Ding D; Ge X; Zhang H; Yao W
    Insights Imaging; 2023 Jun; 14(1):111. PubMed ID: 37336830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic performance of radiomics in predicting axillary lymph node metastasis in breast cancer: A systematic review and meta-analysis.
    Gong X; Guo Y; Zhu T; Peng X; Xing D; Zhang M
    Front Oncol; 2022; 12():1046005. PubMed ID: 36518318
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.
    Granzier RWY; van Nijnatten TJA; Woodruff HC; Smidt ML; Lobbes MBI
    Eur J Radiol; 2019 Dec; 121():108736. PubMed ID: 31734639
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis.
    Tang S; Zhou F; Sun Y; Wei L; Zhu S; Yang R; Huang Y; Yang J
    Breast Cancer; 2016 Nov; 23(6):813-819. PubMed ID: 26898373
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative Prediction Power of Radiomics for Breast Cancer: A Systemic Review and Meta-Analysis.
    Li Z; Ye J; Du H; Cao Y; Wang Y; Liu D; Zhu F; Shen H
    Front Oncol; 2022; 12():837257. PubMed ID: 35299744
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiomics for preoperative prediction of early recurrence in hepatocellular carcinoma: a meta-analysis.
    Tian H; Xie Y; Wang Z
    Front Oncol; 2023; 13():1114983. PubMed ID: 37350952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis.
    Huang J; Tian W; Zhang L; Huang Q; Lin S; Ding Y; Liang W; Zheng S
    Front Oncol; 2020; 10():887. PubMed ID: 32676450
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.